LEO 29102
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for LEO 29102, covering 2025-02-24 to 2025-02-24. Get the full timeline:
Most recent: Clinical Trial Update: A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis [Phase 1]